<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210108049964N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-02-06</date_registration>
      <primary_sponsor>Sabzevar University of Medical Sciences</primary_sponsor>
      <public_title>The effect of Benson relaxation technique on sleep quality in patients with mastectomy</public_title>
      <acronym></acronym>
      <scientific_title>Examining the Effect of Benson's Relaxation Technique on sleep quality among women with Breast Cancer post mastectomy surgery</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-02-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>72</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/53899</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The randomization method in this study is based on quadruple blocks that have been designed based on GPower software. Thus, nineteen quadruple blocks are formed and within each block, two people are considered as intervention persons and two people are considered as controls. The main goal of this method is balance. The number of participants in each group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Breast cancer patients undergoing mastectomy.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:Intervention group includes 36 female patients with breast cancer undergoing mastectomy who, in addition to the usual treatments, perform the Benson relaxation technique twice a day, in the morning and in the afternoon, each time for twenty minutes for two months. Performing the correct Benson relaxation technique This technique is performed in the following sequence. The patient is asked to lie down in a comfortable, quiet place and close his eyes, then gently relax his muscles from the bottom of the body upwards (first the leg muscles relax and then this relaxation continues to the face) and At the same time, slowly begin to breathe deeply, inhaling through the nose and exhaling through the mouth. The patient is asked to whisper number one in order to focus more on his breathing as he exhales. The person continues this position for five minutes and during this time all the muscles of the body are at rest The patient is then asked to open his eyes slowly, so that the body is motionless for a few minutes. It is important to note that one should not worry about deep relaxation. Rather, relaxation should be allowed to occur spontaneously, and if some negative thoughts cause a loss of focus for relaxation, people are asked to ignore these thoughts. Intervention 2: Control group: The control group includes 36 women with breast cancer who have undergone a unilateral mastectomy. The research units in this group perform only the usual pre-study treatments and are controlled for two months in terms of exclusion criteria, etc. They will be followed up and then the sleep quality questionnaire will be completed by them again.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is Due to confidentiality and moral issues and the lack of necessity, there is no plan to publish them.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Raziyeh Chabok</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 25, Behboodi Gharbi Ave</address>
        <city>Kashmar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9675144635</zip>
        <telephone>+98 51 5524 7435</telephone>
        <email>chabokr9@mums.ac.ir</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Mostafa Rad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahrak Tohid Ave</address>
        <city>Sabzevar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9617913114</zip>
        <telephone>+98 51 4401 1000</telephone>
        <email>mostafarad633@yahoo.com</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Unilateral Mastectomy
Ages 30 to 55
Willingness to participate in the study
Have full consciousness
Sleep quality score between 5 and 21 which is considered as poor sleep quality
No other metastatic disease
The patient has undergone all chemotherapy and radiation therapy after surgery and has been controlled for the relevant complications.
No specific physical complications associated with surgery
No severe mental disorders.
Do not use sedatives</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>55 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Occurrence of physical complications related to surgery such as hematoma or serous discharge at the operation site
Accompanying metastatic diseases
Severe mental disorders and the use of sedatives
Patients who underwent surgery before the last four months.
Known neurological disorders such as Parkinson's or multiple sclerosis at the doctor's discretion
Neuromuscular disorders
Use of other therapies while studying</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N60</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Benign mammary dysplasia</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:Intervention group includes 36 female patients with breast cancer undergoing mastectomy who, in addition to the usual treatments, perform the Benson relaxation technique twice a day, in the morning and in the afternoon, each time for twenty minutes for two months. Performing the correct Benson relaxation technique This technique is performed in the following sequence. The patient is asked to lie down in a comfortable, quiet place and close his eyes, then gently relax his muscles from the bottom of the body upwards (first the leg muscles relax and then this relaxation continues to the face) and At the same time, slowly begin to breathe deeply, inhaling through the nose and exhaling through the mouth. The patient is asked to whisper number one in order to focus more on his breathing as he exhales. The person continues this position for five minutes and during this time all the muscles of the body are at rest The patient is then asked to open his eyes slowly, so that the body is motionless for a few minutes. It is important to note that one should not worry about deep relaxation. Rather, relaxation should be allowed to occur spontaneously, and if some negative thoughts cause a loss of focus for relaxation, people are asked to ignore these thoughts.</i_keyword>
      <i_keyword>Control group: The control group includes 36 women with breast cancer who have undergone a unilateral mastectomy. The research units in this group perform only the usual pre-study treatments and are controlled for two months in terms of exclusion criteria, etc. They will be followed up and then the sleep quality questionnaire will be completed by them again</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Percentage of people whose sleep quality score is between 5 and 21. Timepoint: Measurement of sleep quality score at the beginning of the study (before the intervention) and two months after the start of the Benson relaxation technique. Method of measurement: Pittsburgh Sleep Quality Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sabzevar University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-05-19</approval_date>
        <contact_name>Ethics Committee of Sabzevar University of Medical Sciences</contact_name>
        <contact_address>Shahrake Tohid Sabzevar Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
